According to the data from phase 3 clinical trials of the drug in 250 patients across 10 sites, the "drug works best in ...

India's drug regulator has suspended the permission granted to manufacture and sell their new eye drops, PresVu, which ...

Marketed as a potential breakthrough for presbyopia — a common age-related vision issue that makes it difficult to see up ...

Entod Pharmaceuticals denies making false claims about their new PresVu eye drops and plans to challenge the suspension by ...

DCGI suspends Entod Pharma`s eye drop permission for presbyopia treatment due to unapproved claims. The company will ...

The national drugs regulator has suspended its approval for Mumbai-based Entod Pharmaceuticals to make and sell its “PresVu” ...

The Directorate General of Health Services (DGHS), under the Central Drugs Standard Control Organisation (CDSCO), has ...

Drugs Controller General of India, who heads CDSCO, says Entod pharma failed to reply satisfactorily to queries raised. Entod ...

The Drugs Controller General of India (DCGI) has suspended the approval granted to Mumbai-based Entod Pharmaceuticals for ...

DCGI suspends approval for Entod Pharmaceuticals' eye drops due to unauthorised promotion, sparking a likely legal challenge.

The decision follows the company’s claims that its drops could reduce the dependency on reading glasses for individuals ...

CDSCO suspends pharmaceutical company's permission to manufacture eye drops claiming to eliminate reading glasses due to ...